Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Is Better Positioned To Be The Modern Pharmacy

AbbVie

Altria

ONEOK

AT&T

Takeda Pharmaceutical

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth. The post 7 Dividend Stocks Perfect for a Retiree’s Portfolio appeared first on InvestorPlace.

7 Dividend Stocks Perfect for a Retiree’s Portfolio

Sirius XM Holdings Inc

Trupanion

A new quarter means new opportunities to make money for long-term investors.

3 Top Stocks That'll Make You Richer in Q4 and Beyond

Cigna

Centene

Humana

UnitedHealth Group

Health insurance stocks have made fat profits in 2020, but investors are ignoring analyst recommendations in fear of what may happen next year. The post Five Cheap Healthcare Stocks Making Money This Year appeared first on InvestorPlace.

Five Cheap Healthcare Stocks Making Money This Year

CVS Guidance Raise And Fresh Discount: Reiterate Buy

Bank of America

Western Digital

Historically, value stocks have outperformed growth stocks over the very long term.

3 Value Stocks to Buy During a Stock Market Crash

Several of CVS's segments could be considered "mature," which has not historically been good for returns.

CVS: Cheap, Big Growth Potential In PBMs, Tough Competitive Environment

Biogen

Bio-Rad Laboratories

Immunomedics

Livongo Health Inc

Moderna

Insulet

Perrigo

QuidelOrtho Corp

These are the healthcare stocks with the best value, fastest growth, and most momentum for October 2020.

Top Healthcare Stocks for October 2020

Johnson & Johnson

Medtronic

These companies can serve as a solid foundation for a long-term portfolio.

Top 3 Dividend Stocks You'll Want to Own Forever

In the latest trading session, CVS Health (CVS) closed at $57.40, marking a -1.27% move from the previous day.

CVS Health (CVS) Stock Moves -1.27%: What You Should Know

If you're going to invest in a company with a massive brick and mortar footprint, make sure it provides essential goods and services or is building out a tech-like ecosystem.

CVS: Not Just Your Corner Drugstore

CVS is working to position itself for the era of managed care, with low-cost pharmacies and clinics. But will that era arrive?

CVS Health and the Managed Care Strategy

Shares of U.S. health care company CVS Health Corp (NYSE:CVS) are up 5% over the last three trading sessions and 14% since mid-March.

Should You Invest in CVS Health Now?

Walmart

You could add either of these giants to your portfolio, sit back, and watch the gains trickle in -- even in the worst of times.

Market Crash 2.0: 2 Stocks to Buy Right Now to Keep Your Portfolio Safe

Broadcom

Home Depot

Medical Properties Trust

CNBC used TipRanks analyst ranking service to pinpoint Wall Street's best-performing analysts, like Home Depot and Johnson & Johnson.

Wall Street's best performing analysts have a strong buy rating on these 6 dividend stocks

Teladoc

These two healthcare stocks both have their advantages now, but one may be better poised for steady growth.

Better Buy: Teladoc vs. CVS Health

CVS: Value Hiding In Plain Sight

Blue Apron

Guess?

Groupon

Levi Strauss

Under Armour

Urban Outfitters

These cheap stocks are actually supported by strong fundamentals, and won't be on sale for much longer, so snap them up while you can. 
The post 7 Cheap Stocks to Snap Up Before the Market Realizes Their Worth appeared first on InvestorPlace.

7 Cheap Stocks to Snap Up Before the Market Realizes Their Worth

Bristol-Myers

Most stocks are anything but cheap right now. These are three great exceptions.

3 Cheap Stocks You Can Buy and Hold for Decades

CVS Health announced that it will nearly double its Covid-19 drive-thru testing sites by mid-October, bringing the total to more than 4,000 sites nationwide.

Why CVS’ Plan To Double Coronavirus Testing Sites Is Important

Piper Sandler analyst Sarah E. James initiates coverage on CVS Health Corp (NYSE: CVS) with an Overweight rating and a $72 price target.

CVS Is Transforming Health Care, Piper Sandler Says In Upgrade

CVS Health said it would double its drive-thru testing sites for the coronavirus strain Covid-19 to 4,000 while Walgreens confirmed plans to expanding its testing to include employers.

CVS Doubles Covid-19 Test Sites While Walgreens Targets Employers

CVS has decided to become much more than just a chain of drug stores.

CVS Health: A New Vision and Strategy, But Can It Make Money for Investors?

CVS Health's (CVS) consumer centric digital strategy has become even more relevant now.

CVS Health Retail Prescription Volume Grows Despite LTC Woes

CVS Health Corporation: A Look Under The Medical Hood

News for CVS Health Stock (CVS)